4//SEC Filing
Grant Richard N. Jr. 4
Accession 0001062993-25-005902
CIK 0001036262other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:35 PM ET
Size
16.5 KB
Accession
0001062993-25-005902
Insider Transaction Report
Form 4
INTEST CORPINTT
Grant Richard N. Jr.
DirectorPresident & CEO
Transactions
- Award
Employee Stock Option (right to buy)
2025-03-17+43,384→ 43,384 totalExercise: $7.74Exp: 2035-03-16→ Common Stock (43,384 underlying) - Award
Common Stock
2025-03-17+25,840→ 186,897 total - Award
Employee Stock Option (right to buy)
2025-03-17$4.61/sh+2,327$10,727→ 2,327 totalExercise: $7.74Exp: 2035-03-16→ Common Stock (2,327 underlying) - Award
Common Stock
2025-03-17+25,840→ 212,737 total
Holdings
- 30,536
Employee Stock Option (right to buy)
Exercise: $11.33Exp: 2034-03-05→ Common Stock (30,536 underlying) - 112,000
Employee Stock Option (right to buy)
Exercise: $10.62Exp: 2031-03-09→ Common Stock (112,000 underlying) - 16,988
Employee Stock Option (right to buy)
Exercise: $16.06Exp: 2033-03-07→ Common Stock (16,988 underlying) - 25,692
Employee Stock Option (right to buy)
Exercise: $9.76Exp: 2032-03-08→ Common Stock (25,692 underlying)
Footnotes (8)
- [F1]These restricted shares were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 17, 2026.
- [F2]These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 17, 2028 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 38,760.
- [F3]This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 in lieu of an annual base salary merit increase of $10,723. This option will vest in four equal annual installments commencing on March 17, 2026.
- [F4]This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 17, 2026.
- [F5]This option vests in four equal annual installments commencing on March 6, 2025.
- [F6]This option vests in four equal annual installments commencing on March 8, 2024.
- [F7]This option vests in four equal annual installments commencing on March 9, 2023.
- [F8]This option is fully vested as of the date of this report.
Issuer
INTEST CORP
CIK 0001036262
Entity typeother
Related Parties
1- filerCIK 0001821315
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:35 PM ET
- Size
- 16.5 KB